Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
Sumi Biswas(University of Oxford), Simon J. Draper(University of Oxford), Carole A. Long(National Institutes of Health), Adrian V. S. Hill(Jenner Institute), Edmond J. Remarque(Leiden University Medical Center), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Matthew G. Cottingham(University of Oxford), Anthony A. Holder(The Francis Crick Institute), Loredana Siani(Nouscom (Italy)), Matthew D. J. Dicks(University of Oxford), Stefano Colloca(RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy))
Cited by 50
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661